Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: AurumRabosa who wrote (3409)	2/10/2000 6:13:00 PM
From: Terry D.	Respond to of 3702

ron, my mistake. I directed you to a later post. I asked the same question of golfdad. Here is his reply post 1841. Hope this helps. Terry Message 1841 of 1872 Re: imaging golfdad97 (57/M/Houston TX) 1/29/00 3:18 pm Well...just my opinion, since I have no experience in this end of the science. I would think that imaging doses of labeled TNT would be far less than any therapeutic dose, and would fall into the categories of agents such as contrast dyes, radionuclides like Tc which is used to light up bone metastasis, and Prostascint, things like that. Hence, I would look for quick studies on efficacy of this kind of application with a rather quick FDA process.